CCL20 Promotes The Formation Of Hepatic Ectopic Lymphoid-like Structures

Elvira Zino
Lautenberg Center for Immunology and Cancer Research, IMRIC, Hebrew University of Jerusalem, Israel

Introduction: Hepatocellular carcinoma (HCC) is the most common primary liver malignancy. A ubiquitous risk factor for the development of HCC is chronic liver inflammation (hepatitis). Formation of hepatic ectopic lymphoid-like structures (ELSs) is a prominent pathological hallmark of chronic viral hepatitis, which is known to persistently activate IKK-NF-kB signaling. It was shown in our lab that in IKKβ(EE)Hep mice, which express constitutively active IKKβ(EE) in hepatocytes, chronic IKK-NF-kB activation leads to formation of hepatic ELSs, which then promote appearance and growth of HCC. Similarly, an association between NF-kB activation and ELS formation in chronically inflamed human livers was found. Yet, our mouse model reveals that NF-kB activation is not sufficient for ELS induction, which requires additional signals.

There is an increasing interest in the CCL20-CCR6 axis in HCC, as it is highly expressed in a variety of human cancers, including HCC. CCL20 is the only chemokine known to interact with CC chemokine receptor 6 (CCR6). The ligand-receptor pair CCL20-CCR6 is responsible for the chemo-attraction of immature dendritic cells (DC) effector/memory T cells, regulatory T cells and B cells.

This study aims to assess the role of CCL20 signaling in ELS formation.

Materials and Methods: First, using immunohistochemical analysis, we identified that CCL20 is expressed in all HCC progenitor lesions in IKKβ(EE)Hep mice. In order to assess a causative role of the CCL20-CCR6 axis in ELS and HCC induced by chronic low grade NF-ĸB activation, we used two approaches: (1) Disruption of CCL20 signaling by crossing IKKβ(EE)Hep mice with CCR6 KO mice; (2) Overexpression of CCL20 specifically in the hepatocytes of IKKβ(EE)Hep mice.

Results and Discussion: The disruption of CCL20 signaling in IKKβ(EE)Hep mice resulted in reduced liver infiltration by lymphocytes, attenuated ELS neogenesis and reduced HCC tumorigenesis. CCL20 overexpression specifically in the hepatocytes of IKKβ(EE)Hep mice accelerated the formation of ELSs.

Conclusion: Our results suggest a central role for the CCL20-CCR6 axis in ELS formation, as CCR6 depletion significantly attenuates ELS neogenesis and HCC load in IKKβ(EE)Hep mice. Further studies are planned to define the mechanisms and immune cell types through which CCL20-CCR6 induce formation of ELSs and HCC.





Organizing Company: Ortra Ltd. 94 Yigal Alon St. Tel Aviv, Israel,
Tel: 972-3-6384444 Fax: 972-3-6384455
cancerconf@ortra.com





Powered by Eventact EMS